October 12, 2023 BY Elizabeth Anderson
Success of Ozempic kidney failure trials proves disastrous for dialysis stocks
The company indicated the trial would come to an end, approximately a year before scheduled completion, following a recommendation from an independent data monitoring committee. Ozempic, a treatment commonly used for Type 2 Diabetes, contains semaglutide. The trial aimed to discover if it could stem the progress of kidney disease and help with associated complications. …
Read more